Trends in Drug Discovery in Diabetes and Obesity, 1st Edition

Trends in Drug Discovery in Diabetes and Obesity, 1st Edition
Summary
Drug discovery strategies for next-generation anti-diabetic and anti-obesity therapies Diabetes ranks as the seventh leading cause of death globally, claiming 1.5 million victims annually, yet the complexity of energy metabolism makes pharmaceutical intervention difficult—often requiring simultaneous modulation of multiple drug targets. Trends in Drug Discovery in Diabetes and Obesity assembles drug developers from pharma companies who share hard-to-find insight on strategies for developing more efficient therapies. The book surveys critical drug classes including GLP-1 receptor agonists, GIP antagonists, poly-agonist drugs, and long-acting insulin variants, covering both peptide and small molecule approaches. Selected case studies detail the discovery pathways of recently approved drugs, providing direct insight into the decision-making and optimization processes that led fr